{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:50:11Z","timestamp":1790815811131,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jaccas.2020.07.033","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T14:00:30Z","timestamp":1601474430000},"page":"2095-2100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lenalidomide-Induced Myocarditis, Rare\u00a0But Possibly Fatal Toxicity of a Commonly Used Immunotherapy"],"prefix":"10.1016","volume":"2","author":[{"given":"Robin","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Strati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-1797","authenticated-orcid":false,"given":"Nicolas","family":"Palaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Lopez-Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Marmagkiolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Maximilian","family":"Buja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2020.07.033_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40266-015-0269-6","article-title":"Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation","volume":"32","author":"Mccormack","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jaccas.2020.07.033_bib2","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJMoa1112704","article-title":"Continuous lenalidomide treatment for newly diagnosed multiple myeloma","volume":"366","author":"Palumbo","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccas.2020.07.033_bib3","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1200\/JCO.2005.05.0401","article-title":"Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study","volume":"24","author":"Chanan-Khan","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccas.2020.07.033_bib4","doi-asserted-by":"crossref","first-page":"145665","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5Q deletion","volume":"355","author":"List","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccas.2020.07.033_bib5","first-page":"355","article-title":"Acute eosinophilic myocarditis mimicking myocardial infarction","volume":"30","author":"Thambidoral","year":"2009","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jaccas.2020.07.033_bib6","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1200\/JCO.2006.08.4053","article-title":"Lenalidomide-induced warm autoimmune hemolytic anemia","volume":"24","author":"Darabi","year":"2006","journal-title":"J\u00a0Clin Onco1"},{"key":"10.1016\/j.jaccas.2020.07.033_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1378\/chest.06-1734","article-title":"Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide","volume":"131","author":"Thornburg","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jaccas.2020.07.033_bib8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1345\/aph.1P044","article-title":"Myocarditis during lenalidomide therapy","volume":"44","author":"Carver","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaccas.2020.07.033_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.14562","article-title":"Upfront lower dose lenalidomide less toxic and does not compromise efficacy for patients with relapsed refractory multiple myeloma","volume":"117","author":"Quach","year":"2017","journal-title":"Br J Haematol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084920309098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084920309098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:47:29Z","timestamp":1762973249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084920309098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":9,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2666084920309098"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2020.07.033","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenalidomide-Induced Myocarditis, Rare\u00a0But Possibly Fatal Toxicity of a Commonly Used Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2020.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}